Total visits last 3 months
| Last Month Change | 14.48% | 13.59% |
| Avg Visit Duration | 00:00:16 | 00:00:37 |
| Pages per Visit | 1.5 | 1.95 |
| Bounce Rate | 58.77% | 40.72% |
| Compare any site with a free trial | ||
akerotx.com VS. 
89bio.com
akerotx.com
Our flagship EFX program is designed to be a differentiated, potentially best-in-class treatment for metabolic dysfunction-associated steatohepatitis (MASH).
Global Rank
#2,918,276
89bio.com
Clinical-stage biopharmaceutical company dedicated to developing and delivering innovative therapies to treat people with liver and cardiometabolic diseases.
Global Rank
#2,849,589
akerotx.com vs. 89bio.com Ranking Comparison
Compare akerotx.com global ranking trend in the past 3 months vs. 89bio.com, or dive deeper into akerotx.com ranking in its category or country measured against 89bio.com
Category Rank Last Month
akerotx.com
#70989bio.com
#1,002
Traffic and Engagement
akerotx.com had more total visits compared to 89bio.com in May 2026.
Traffic share by country: akerotx.com vs. 89bio.com
akerotx.com vs 89bio.com country based traffic analysis shows akerotx.com gets the most traffic from United States, while 89bio.com gets a smaller share
Top Countries
akerotx.com
71.92%
89bio.com
28.08%
United States